Evonik Industries AG is a specialty chemicals company. The company is organized into three segments: Custom Solutions, Advanced Technologies, and Infrastructure. Its products and services serve markets including animal nutrition and health, automotive and transportation, building and construction, coatings and paints, consumer goods, electronics and telecommunications, energy and utilities, industrial manufacturing, lubricants, oil and gas, and textiles. Evonik was founded in 1847 as Chemische Fabrik Th. Goldschmidt and was renamed Evonik Industries AG in 2007.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Specialty Chemicals Homepage evonik.com
Sector Basic Materials IR page evonik.com/en/investor-relations.html
Tags
specialty chemicals, animal nutrition, automotive chemicals, coatings additives, consumer goods ingredients, electronics chemicals, industrial lubricants, textile chemicals, energy solutions, Custom Solutions, Advanced Technologies, Infrastructure
Press page —

Metrics

Valuation  
Market cap € 9.805B
Market cap (USD) $ 10.836B
P/E 56.86
PEG —
P/BV 1.21
P/S 0.70
P/OCF 5.40
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 3.1%
ROI 3.2%
ROIC 3.2%
Profit margin 1.9%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -21.8%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -11.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011
Revenue 14.069B 15.157B 15.267B 18.488B 14.955B 12.199B 13.108B 15.024B 14.419B 12.732B 13.507B 12.917B 12.874B 13.629B 14.54B
Net profit 265M 240M -452M 555M 767M 479M 2.127B 932M 717M 844M 991M 568M 2.054B 1.164B 1.011B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011
Share price 13.36 16.73 18.5 17.94 28.47 26.68 27.21 23.86 28.38 28.38 30.62 — — — —
Price performance 12m -0.2 -0.1 0.03 -0.37 0.07 -0.02 0.14 -0.16 0 -0.07 — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

The Executive Board of Evonik Industries AG has carefully reviewed the letter from BASF SE dated October 22, 2026, expressing its interest in making a voluntary public takeover offer. Based on the information available, the Executive Board has decided not to enter into negotiations with BASF SE. The Executive Board remains focused on its strategic direction and further development of Evonik as an independent company.

At the same time, the Executive Board has expressed its willingness to engage in a purely informational and confidential exchange with BASF SE in order to explain Evonik Industries AG’s position and to give BASF SE the opportunity to outline its rationale and the key considerations underlying its interest.

Contacts

 Christoph Finke

Christoph Finke

Senior Vice President Investor Relations

Spoken languages: deutsch, englisch

+49 174 9931647 Send email

Downloads

Download as PDF

Evonik: Leading beyond chemistry

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Evonik Industries AG
Opernplatz 1
45128 Essen
Germany

Phone +49 201 177-01
www.evonik.com

Supervisory Board Bernd Tönjes, Chairman Executive Board Christian Kullmann, Lauren Kjeldsen, Dr. Claudine Mollenkopf, Michael Rauch, Deputy Chairman Dr. Claus Rettig, Thomas Wessel

Registered Office is Essen Register Court Essen Local Court Commercial Registry B 19474

Online version press release

Evonik on social media

LinkedIn Evonik

YouTube Evonik

Instagram Evonik

Facebook Evonik

TikTok Evonik

WeChat Evonik

Company Information Legal Notice Privacy Policy Contact

Prompts

Evonik Industries AG (ticker EVK), listed in Germany.

ETFs Holding Evonik Industries AG

ETF Weight in ETF Shares Market value As of
DTAN 0.70% 6,251 $ 151.921K Nov 17, 2026
DISV 0.68% 1,495,208 $ 34.748M Nov 12, 2026
AIVI 0.66% 21,409 $ 388.693K Jun 30, 2026
FENI 0.29% 1,620,552 $ 29.404M Jun 30, 2026
SEIE 0.22% 137,741 $ 2.501M Jun 30, 2026
RINT 0.21% 16,224 $ 294.376K Jun 30, 2026
DFIS 0.21% 519,918 $ 12.083M Nov 12, 2026
DXIV 0.10% 10,391 $ 241.483K Nov 12, 2026
RGLO 0.10% 18,101 $ 328.433K Jun 30, 2026
AVDE 0.06% 526,923 $ 12.241M Nov 16, 2026
AVSD 0.06% 10,080 $ 234.161K Nov 16, 2026
DFSI 0.06% 30,547 $ 709.9K Nov 12, 2026
DFIC 0.06% 374,801 $ 8.71M Nov 12, 2026
DFAX 0.04% 207,231 $ 4.816M Nov 12, 2026
DFAI 0.03% 202,212 $ 4.699M Nov 12, 2026
AVIV 0.00% 879 $ 20.419K Nov 16, 2026